Biochemistry
8 questionsKetone bodies are not used by?
What is essential for the transfer of fatty acid across the mitochondrial membrane?
Krabbe's disease is due to deficiency of ?
What is the normal range of ferritin levels in adult males?
In type IA Maple Syrup Urine Disease, which gene mutation is responsible?
Which type of bond is primarily responsible for the primary structure of a protein?
What is the typical Q10 value for enzymatic reactions?
Amino acid with aliphatic side chain is?
NEET-PG 2013 - Biochemistry NEET-PG Practice Questions and MCQs
Question 201: Ketone bodies are not used by?
- A. Brain
- B. Muscle
- C. RBC (Correct Answer)
- D. Renal cortex
Explanation: ***RBC*** - Red blood cells **lack mitochondria**, which are essential organelles for the **oxidation of ketone bodies** (acetoacetate and β-hydroxybutyrate) for energy production. - Their primary energy source is **anaerobic glycolysis** of glucose. *Muscle* - **Skeletal and cardiac muscles** readily utilize **ketone bodies** as an alternative fuel source, especially during prolonged fasting or starvation. - This helps to conserve glucose for other tissues, particularly the brain. *Brain* - The brain can adapt to use **ketone bodies** for energy when glucose supply is limited, such as during prolonged fasting or in cases of uncontrolled diabetes. - This process is crucial for brain function when glucose levels are low. *Renal cortex* - The **renal cortex** is capable of utilizing **ketone bodies** for energy, particularly during starvation. - The kidney is also involved in the **synthesis of glucose** (gluconeogenesis) and the excretion of ketone bodies.
Question 202: What is essential for the transfer of fatty acid across the mitochondrial membrane?
- A. Creatinine
- B. Carnitine (Correct Answer)
- C. Biotin
- D. Creatine
Explanation: ***Carnitine*** - **Carnitine** is crucial for transporting **long-chain fatty acids** into the mitochondrial matrix for **beta-oxidation**. - It forms **acylcarnitine** by esterifying with fatty acids, allowing passage through the inner mitochondrial membrane via the **carnitine-acylcarnitine translocase**. *Creatinine* - **Creatinine** is a waste product formed from the breakdown of **creatine phosphate** in muscles and is excreted by the kidneys. - It serves as a marker for **kidney function** and has no role in fatty acid transport. *Biotin* - **Biotin** is a vitamin cofactor essential for **carboxylase enzymes**, including acetyl-CoA carboxylase in **fatty acid synthesis**. - While involved in lipid metabolism, it plays no role in the transport of fatty acids across mitochondrial membranes. *Creatine* - **Creatine** is a nitrogenous organic acid that helps supply energy to cells, primarily muscle, by facilitating the regeneration of **ATP**. - It plays no direct role in the facilitated transport of fatty acids across the mitochondrial membrane.
Question 203: Krabbe's disease is due to deficiency of ?
- A. Sphingomyelinase
- B. Beta galactocerebrosidase (Correct Answer)
- C. Hexosaminidase
- D. Arylsulfatase
Explanation: ***Beta galactocerebrosidase*** - Krabbe's disease is specifically caused by a deficiency of **beta-galactocerebrosidase**, leading to the accumulation of toxic substances in the brain [1]. - This disease predominantly affects the **myelin sheath**, resulting in severe neurological deterioration [1]. *Arylsulfatase* - Deficiency of **arylsulfatase** is associated with **metachromatic leukodystrophy**, not Krabbe's disease. - Symptoms and pathology differ significantly, primarily affecting **sulfatides** rather than galactocerebrosides. *Sphingomyelinase* - A deficiency of **sphingomyelinase** is linked to **Niemann-Pick disease**, characterized by splenomegaly and liver involvement. - This condition does not involve the same neurological deterioration seen in Krabbe's disease. *Hexosaminidase* - Hexosaminidase deficiency is associated with **Tay-Sachs disease**, primarily affecting the **GM2 gangliosides** [2]. - This results in different clinical manifestations, such as **cherry-red spots** and progressive neurodegeneration, rather than the symptoms of Krabbe's disease [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1304-1305. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 161.
Question 204: What is the normal range of ferritin levels in adult males?
- A. 30-300 ng/ml (Correct Answer)
- B. 300-500 ng/ml
- C. 10-20 ng/ml
- D. 500-700 ng/ml
Explanation: ***30-300 ng/ml*** - The normal range for **ferritin levels** in adult males is typically **30-300 ng/ml** (some laboratories report 30-400 ng/ml). - Ferritin is an **iron storage protein**, and its levels reflect the body's iron stores. - Values below 30 ng/ml suggest **iron deficiency**, while values above 300 ng/ml may indicate iron overload or inflammatory conditions. *10-20 ng/ml* - These levels are **significantly low** and indicate **iron deficiency**. - This range is well below the normal threshold and would warrant investigation and likely iron supplementation. - Levels below 15 ng/ml are diagnostic of **iron deficiency** even in the absence of anemia. *300-500 ng/ml* - Levels in this range are considered **elevated** and can indicate iron overload, chronic inflammation, liver disease, or malignancy. - While some laboratories extend the upper limit to 400 ng/ml, persistent elevation above 300 ng/ml warrants further investigation. - Common causes include **hemochromatosis**, **chronic liver disease**, or **inflammatory conditions**. *500-700 ng/ml* - These levels are **significantly elevated** and strongly suggest **iron overload conditions** such as **hemochromatosis**, severe inflammatory states, or hepatocellular injury. - High ferritin levels can be associated with organ damage, leading to conditions like **cirrhosis** or **cardiomyopathy**. - Requires urgent investigation to identify the underlying cause.
Question 205: In type IA Maple Syrup Urine Disease, which gene mutation is responsible?
- A. BCKDHB
- B. DBT
- C. DLD
- D. BCKDHA (Correct Answer)
Explanation: ***BCKDHA*** - **Maple Syrup Urine Disease (MSUD)** type IA is caused by a mutation in the **BCKDHA gene**, which codes for the E1α subunit of the **branched-chain α-keto acid dehydrogenase (BCKD) complex**. - This **enzyme complex** is crucial for the metabolism of **branched-chain amino acids (BCAAs)**: leucine, isoleucine, and valine. *BCKDHB* - The **BCKDHB gene** codes for the E1β subunit of the **BCKD complex**. - Mutations in **BCKDHB** are associated with **type IB MSUD**, not type IA. *DBT* - The **DBT gene** codes for the E2 subunit (dihydrolipoyl transacylase) of the **BCKD complex**. - Mutations in **DBT** are responsible for **type II MSUD**. *DLD* - The **DLD gene** codes for the E3 subunit (dihydrolipoyl dehydrogenase), which is a component shared by several **α-keto acid dehydrogenase complexes**. - Mutations in the **DLD gene** lead to **type III MSUD** and other pyruvate dehydrogenase complex deficiencies, rather than type IA.
Question 206: Which type of bond is primarily responsible for the primary structure of a protein?
- A. Hydrogen bond
- B. Disulfide bond
- C. Peptide bond (Correct Answer)
- D. Electrostatic bond
Explanation: ***Peptide bond*** - The **primary structure** of a protein is defined by the unique linear sequence of **amino acids** linked together by **peptide bonds**. - These are **amide bonds** formed between the carboxyl group of one amino acid and the amino group of another, with the elimination of water. *Hydrogen bond* - **Hydrogen bonds** are crucial for the **secondary structure** (e.g., alpha-helices and beta-sheets) and **tertiary/quaternary structures** of proteins, stabilizing their 3D folds. - They involve interactions between polar atoms, not the direct linkage of amino acids in the primary sequence. *Disulfide bond* - **Disulfide bonds** are **covalent bonds** formed between the sulfur atoms of two **cysteine residues**, contributing to the **tertiary** and sometimes **quaternary structure** stability. - They are not involved in forming the linear sequence of amino acids, which is the primary structure. *Electrostatic bond* - **Electrostatic bonds**, or **ionic bonds**, occur between oppositely charged amino acid side chains and are important for **tertiary** and **quaternary structure** stability. - They do not form the backbone of the protein's primary sequence.
Question 207: What is the typical Q10 value for enzymatic reactions?
- A. 2 (Correct Answer)
- B. 3
- C. 4
- D. 5
Explanation: ***2*** - The **Q10 value** represents the factor by which the rate of a reaction increases for every 10°C rise in temperature. - For most enzymatic and biological reactions, the **Q10 value** is typically around **2 to 3**. *3* - While **3** is within the typical range for some biological reactions, **2** is often considered the most common or average value cited for enzymatic reactions. - A **Q10 of 3** means the reaction rate triples with a 10°C increase, which is observed in certain cases but is not the most general "typical" value. *4* - A **Q10 value of 4** indicates a significantly higher temperature sensitivity than what is commonly observed for most enzymatic reactions. - Such a high Q10 would imply that the reaction rate quadruples for every 10°C increase, which is less typical. *5* - A **Q10 value of 5** is exceptionally high and rarely observed for common enzymatic reactions under physiological conditions. - This would suggest an extreme sensitivity to temperature changes, which is not characteristic of most enzyme kinetics.
Question 208: Amino acid with aliphatic side chain is?
- A. Serine
- B. Leucine (Correct Answer)
- C. Threonine
- D. Aspartate
Explanation: ***Leucine*** - Leucine has an **isobutyl group** (-CH2CH(CH3)2) as its side chain, making it a **nonpolar aliphatic amino acid**. - **Aliphatic amino acids** (glycine, alanine, valine, leucine, isoleucine, proline) have side chains consisting of only carbon and hydrogen atoms in straight or branched chains, with **no polar functional groups**. - These amino acids are **hydrophobic** and typically found in the interior of proteins. *Serine* - Serine has a **hydroxyl group** (-OH) in its side chain (-CH2OH), classifying it as a **polar uncharged amino acid**, not an aliphatic amino acid. - The hydroxyl group makes the side chain **hydrophilic** and capable of hydrogen bonding. - The presence of the polar functional group distinguishes it from aliphatic amino acids. *Threonine* - Threonine also contains a **hydroxyl group** (-OH) in its side chain (-CH(OH)CH3), making it a **polar uncharged amino acid**, not an aliphatic amino acid. - Like serine, the hydroxyl group provides **polarity and hydrogen bonding capacity**. - This functional group places it in a different classification from aliphatic amino acids. *Aspartate* - Aspartate has a **carboxyl group** (-COOH) in its side chain (-CH2COOH), making it an **acidic (negatively charged) amino acid**. - At physiological pH, this group is deprotonated (COO⁻), making aspartate **negatively charged**. - This clearly distinguishes it from nonpolar aliphatic amino acids.
Internal Medicine
1 questionsPrimary hypercholesterolemia is:
NEET-PG 2013 - Internal Medicine NEET-PG Practice Questions and MCQs
Question 201: Primary hypercholesterolemia is:
- A. Type I
- B. Type IIb
- C. Type IIa (Correct Answer)
- D. Type III
Explanation: ***Type Ha*** - **Primary hypercholesterolemia** specifically refers to **Familial Hypercholesterolemia**, which is classified as Type Ha due to a genetic defect affecting LDL receptor activity [1]. - It typically presents with **high cholesterol levels** and an increased risk of premature cardiovascular disease [1]. *Type I* - Type I hyperlipoproteinemia is associated with **chylomicronemia**, leading to elevated triglycerides rather than cholesterol. - Symptoms include **pancreatitis** and eruptive xanthomas, not primarily high cholesterol levels. *Type III* - Type III hyperlipoproteinemia is known as **Dysbetalipoproteinemia**, associated with **increased IDL** and can cause elevated cholesterol, but is not classified as primary hypercholesterolemia. - It typically presents with **tuberous xanthomas** and is linked to **apolipoprotein E deficiency**. *Type IIb* - Type IIb hyperlipoproteinemia involves **elevation of LDL and VLDL**, but it is not classified as primary hypercholesterolemia; it is a mixed dyslipidemia. - This type usually features **increased cholesterol** and **triglycerides**, distinguishing it from the familial form classified as Type Ha.
Pathology
1 questionsWhich of the following statements is true regarding light microscopy findings in minimal change disease?
NEET-PG 2013 - Pathology NEET-PG Practice Questions and MCQs
Question 201: Which of the following statements is true regarding light microscopy findings in minimal change disease?
- A. Foot process effacement is observed under electron microscopy, not light microscopy.
- B. Anti-GBM antibodies are associated with Goodpasture syndrome, not minimal change disease.
- C. No significant changes are seen under light microscopy. (Correct Answer)
- D. IgA deposits are characteristic of IgA nephropathy, not minimal change disease.
Explanation: ***No change seen*** - In minimal change disease, **light microscopy** typically shows no significant changes, which is a key characteristic of the condition [1]. - The disease primarily affects the **podocytes** leading to **nephrotic syndrome**, while light microscopy does not reveal any abnormalities [1]. *Loss of foot process seen* - Loss of foot processes is actually observed under **electron microscopy**, not light microscopy. - Light microscopy remains normal, differentiating minimal change disease from other glomerular diseases. *IgA deposits seen* - IgA deposits are associated with **IgA nephropathy**, which is a different condition characterized by mesangial deposition. - Minimal change disease does not have **immunofluorescence** findings, and thus shows no such deposits on light microscopy [1]. *Anti GBM Abs seen* - Anti-GBM antibodies are characteristic of **Goodpasture syndrome**, which presents with significant changes in glomerular structure. - In minimal change disease, there are no **anti-GBM antibodies** or major changes visible under light microscopy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 927-928.